Elizabeth Acuna: The current medications available for atopic dermatitis [cover] a wide range. When I started out with the disease state, very young, I started with the cortisones, the steroids. I did all the topical creams and the normal regimen, step by step. I know it helps some people, but unfortunately, it doesn’t help some other people. With that being said, I was in the later class. Those medications didn’t help me. I went on to some immunosuppressants and some really heavy medications, obviously with some pretty tough side effects that weren’t welcomed.
So, to where I am now with dupilumab, it’s been completely life changing. I had 30 some years of having no luck, having frustrations, and continued rashes and continued struggles. And, then, all of a sudden, it’s just been a life-changing event for me, so I can’t say enough about the impact that it has had. I think when you have atopic dermatitis, and I’ve had it for my entire life, you almost just start to cope with it. It almost becomes your normal; my own normal. And then, once this happened, it’s life changing. I know it. I can feel it, I see it, I experience it, but it’s even more impactful when your parents look at you and they’re like, “Oh my god, you look great” or even look at old pictures. I’m like, “Oh my god, I can’t believe I looked that bad.” It’s definitely been a long process, but I’m very, very happy where I am today.
I don’t experience any side effects with dupilumab. I’ve never had an adverse reaction that I’ve ever called into the study with the protocols. So, for me, it has all been 100% beneficial. [There is] nothing that I can take away that has been an issue for me.
Contributor: More Informed Management of Preeclampsia Is Necessary
November 29th 2023At present, it is difficult for clinicians to identify patients at greatest risk for developing preeclampsia with severe features and tailor treatment plans for them; this difficulty increases costs significantly.
Read More
Oncology Onward: A Conversation With Dr Shereef Elnahal, Under Secretary for Health
April 20th 2023Shereef Elnahal, MD, MBA, under secretary for health at the Veterans Health Administration (VHA), sat for a conversation with our hosts Emeline Aviki, MD, MBA, Memorial Sloan Kettering Cancer Center, and Stephen Schleicher, MD, MBA, Tennessee Oncology, that covered the cancer footprint of the VHA.
Listen
Provisional CDC data show that US babies gained roughly a year in life expectancy in 2022; study findings indicate that the COVID-19 pandemic significantly raised the risk of preterm birth for expectant California mothers; New York Attorney General Letitia James said about 4 million New Yorkers were affected by a data breach of the medical transcription company Perry Johnson & Associates.
Read More
Understanding the Unmet Need for Therapies to Treat Rare Bile Duct Cancer
May 24th 2022On this episode of Managed Care Cast, we bring you an excerpt of an interview with a co-chair of the 2022 Cholangiocarcinoma Foundation (CCF) annual conference, held earlier this year, about the significant unmet therapy needs facing most patients with this rare cancer.
Listen
Gene Therapy Success in UK Likely Depends on Overcoming Education, Psychological Support Challenges
November 27th 2023Education, psychological support, and implementation guidance are the top unmet needs identified by investigators from the United Kingdom concerning gene therapy use for hemophilia.
Read More